Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease

Eur J Intern Med. 2017 Jan:37:83-89. doi: 10.1016/j.ejim.2016.10.004. Epub 2016 Oct 21.

Abstract

Background & aims: Recent studies documented an increased cardiovascular risk in patients with inflammatory bowel disease (IBD). Our study aimed at investigating the prevalence of intima-media thickness (IMT) of the carotid arteries and the arterial stiffness indices as markers of early atherosclerosis in young IBD patients.

Methods: We recruited 68 consecutive IBD patients, and 38 matched healthy controls less than 45years old (median age 31.6±8.1years). Clinical and demographic features, cardiovascular risk factors, history of cardiovascular events, concomitant therapies were registered on a dedicate database. Carotid IMT was evaluated by using high resolution B-mode ultrasonography. Arterial stiffness was assessed by measurement of carotid-femoral Pulse Wave Velocity (PWV) and Augmentation Index (AIx).

Results: Total cholesterol (P<0.013) and LDL-cholesterol (P<0.019) levels were significantly lower in IBD patients compared to controls. Carotid IMT was higher in IBD than in controls (P<0.047), but there was no statistically significant difference among Crohn's Disease (CD) and Ulcerative Colitis (UC) patients. Moreover, PWV and AIx were significantly higher in patients as compared to controls (P<0.006 and P<0.004 respectively). No medication seemed to affect vascular measurements, though stiffness parameters were significantly higher in patients treated with 5-ASA (11.9 (9.7) vs 18.2 (10.2), P<0.021), suggesting a lack of efficacy of 5-ASA in protecting IBD patients from early atherogenesis.

Conclusions: Young IBD patients show an increase in subclinical markers of atherosclerosis. Future studies need to address whether these markers result in an increased risk of cardiovascular events in these patient.

Keywords: Arterial stiffness; Carotid intima-media thickness; Early atherosclerosis; IBD.

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Atherosclerosis / blood
  • Atherosclerosis / diagnostic imaging*
  • Atherosclerosis / epidemiology
  • Atherosclerosis / physiopathology
  • Biomarkers / blood
  • Carotid Arteries / diagnostic imaging*
  • Carotid Intima-Media Thickness
  • Case-Control Studies
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Colitis, Ulcerative / drug therapy*
  • Colitis, Ulcerative / epidemiology
  • Crohn Disease / drug therapy*
  • Crohn Disease / epidemiology
  • Female
  • Humans
  • Inflammatory Bowel Diseases / drug therapy
  • Inflammatory Bowel Diseases / epidemiology
  • Male
  • Mesalamine / therapeutic use*
  • Pulse Wave Analysis
  • Risk Factors
  • Triglycerides / blood
  • Vascular Stiffness*
  • Young Adult

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Biomarkers
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Triglycerides
  • Mesalamine
  • Cholesterol